Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation

K. Kovacovicova, M. Vinciguerra,

. 2019 ; 52 (6) : e12674. [pub] 20190913

Language English Country Great Britain

Document type Journal Article

Grant support
CZ.02.1.01/0.0/0.0/15_003/0000492 European Social Fund and European Regional Development Fund
European Social Fund
European Regional Development Fund

OBJECTIVES: Chemotherapeutic drugs induce senescence in cancer cells but, unlike replicative senescence or oncogene-induced senescence, do so rather inefficiently and depending on DNA damage. A thorough understanding of the biology of chemotherapy-induced senescent cells requires their isolation from a mixed population of adjacent senescent and non-senescent cancer cells. MATERIALS AND METHODS: We have developed and optimized a rapid iodixanol (OptiPrep)-based gradient centrifugation system to identify, isolate and characterize doxorubicin (DXR)-induced senescent hepatocellular carcinoma (HCC) cells (HepG2 and Huh-7) in vitro. RESULTS: After cellular exposure to DXR, we used iodixanol gradient-based centrifugation to isolate and re-plate cells on collagen-coated flasks, despite their low or null proliferative capacity. The isolated cell populations were enriched for DXR-induced senescent HCC cells, as confirmed by proliferation arrest assay, and β-galactosidase and DNA damage-dependent γH2A.X staining. CONCLUSIONS: Analysing pure cultures of chemotherapy-induced senescent versus non-responsive cancer cells will increase our knowledge on chemotherapeutic mechanisms of action, and help refine current therapeutic strategies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044534
003      
CZ-PrNML
005      
20200113105444.0
007      
ta
008      
200109s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cpr.12674 $2 doi
035    __
$a (PubMed)31517418
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kovacovicova, Kristina $u Center for Translational Medicine, International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic.
245    10
$a Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation / $c K. Kovacovicova, M. Vinciguerra,
520    9_
$a OBJECTIVES: Chemotherapeutic drugs induce senescence in cancer cells but, unlike replicative senescence or oncogene-induced senescence, do so rather inefficiently and depending on DNA damage. A thorough understanding of the biology of chemotherapy-induced senescent cells requires their isolation from a mixed population of adjacent senescent and non-senescent cancer cells. MATERIALS AND METHODS: We have developed and optimized a rapid iodixanol (OptiPrep)-based gradient centrifugation system to identify, isolate and characterize doxorubicin (DXR)-induced senescent hepatocellular carcinoma (HCC) cells (HepG2 and Huh-7) in vitro. RESULTS: After cellular exposure to DXR, we used iodixanol gradient-based centrifugation to isolate and re-plate cells on collagen-coated flasks, despite their low or null proliferative capacity. The isolated cell populations were enriched for DXR-induced senescent HCC cells, as confirmed by proliferation arrest assay, and β-galactosidase and DNA damage-dependent γH2A.X staining. CONCLUSIONS: Analysing pure cultures of chemotherapy-induced senescent versus non-responsive cancer cells will increase our knowledge on chemotherapeutic mechanisms of action, and help refine current therapeutic strategies.
650    _2
$a hepatocelulární karcinom $x patologie $7 D006528
650    12
$a separace buněk $x metody $7 D002469
650    _2
$a stárnutí buněk $x účinky léků $7 D016922
650    _2
$a poškození DNA $x účinky léků $7 D004249
650    _2
$a doxorubicin $x farmakologie $7 D004317
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x patologie $7 D008113
650    _2
$a kyseliny trijodbenzoové $x farmakologie $7 D014283
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vinciguerra, Manlio $u Center for Translational Medicine, International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic.
773    0_
$w MED00001074 $t Cell proliferation $x 1365-2184 $g Roč. 52, č. 6 (2019), s. e12674
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31517418 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113105816 $b ABA008
999    __
$a ok $b bmc $g 1482803 $s 1083207
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 52 $c 6 $d e12674 $e 20190913 $i 1365-2184 $m Cell proliferation $n Cell Prolif $x MED00001074
GRA    __
$a CZ.02.1.01/0.0/0.0/15_003/0000492 $p European Social Fund and European Regional Development Fund
GRA    __
$p European Social Fund
GRA    __
$p European Regional Development Fund
LZP    __
$a Pubmed-20200109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...